000154151 001__ 154151
000154151 005__ 20240229123056.0
000154151 0247_ $$2doi$$a10.1007/s00103-020-03114-x
000154151 0247_ $$2pmid$$apmid:32185449
000154151 0247_ $$2ISSN$$a1436-9990
000154151 0247_ $$2ISSN$$a1437-1588
000154151 0247_ $$2altmetric$$aaltmetric:87185672
000154151 037__ $$aDKFZ-2020-00612
000154151 041__ $$ager
000154151 082__ $$a610
000154151 1001_ $$aHassenstein, Max J$$b0
000154151 245__ $$a[Self-reported infections in the German National Cohort (GNC) in the context of the current research landscape].
000154151 260__ $$aHeidelberg$$bSpringer$$c2020
000154151 3367_ $$2DRIVER$$aarticle
000154151 3367_ $$2DataCite$$aOutput Types/Journal article
000154151 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1586860431_11878
000154151 3367_ $$2BibTeX$$aARTICLE
000154151 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154151 3367_ $$00$$2EndNote$$aJournal Article
000154151 500__ $$a2020 Apr;63(4):404-414.
000154151 520__ $$aInfectious diseases continue to play an important role for disease perception, health-economic considerations and public health in Germany. In recent years, infectious diseases have been linked to the development of non-communicable diseases. Analyses of the German National Cohort (GNC) may provide deeper insights into this issue and pave the way for new targeted approaches in disease prevention.The aim was to describe the tools used to assess infectious diseases and to present initial data on infectious disease frequencies, as well as to relate the GNC assessment tools to data collection methods in other studies in Germany.As part of the baseline examination, questions regarding infectious diseases were administered using both an interview and a self-administered touchscreen questionnaire. Data from the initial 101,787 GNC participants were analysed.In the interview, 0.2% (HIV/AIDS) to 8.6% (shingles) of respondents reported ever having a medical diagnosis of shingles, postherpetic neuralgia (in cases where shingles was reported), hepatitis B/C, HIV/AIDS, tuberculosis or sepsis if treated in hospital. In the questionnaire, 12% (cystitis) to 81% (upper respiratory tract infections) of respondents reported having experienced at least one occurrence of upper or lower respiratory tract infections, gastrointestinal infections, cystitis or fever within the past 12 months.The cross-sectional analyses of data and tools presented here - for example on determinants of susceptibility to self-reported infections - can be anticipated from the year 2021 onward. Beyond that, more extensive research into infectious disease epidemiology will follow, particularly once analyses of GNC biological materials have been performed.
000154151 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000154151 588__ $$aDataset connected to CrossRef, PubMed,
000154151 7001_ $$aAarabi, Ghazal$$b1
000154151 7001_ $$aAhnert, Peter$$b2
000154151 7001_ $$aBecher, Heiko$$b3
000154151 7001_ $$aFranzke, Claus-Werner$$b4
000154151 7001_ $$aFricke, Julia$$b5
000154151 7001_ $$aKrause, Gérard$$b6
000154151 7001_ $$aGlöckner, Stephan$$b7
000154151 7001_ $$aGottschick, Cornelia$$b8
000154151 7001_ $$aKarch, André$$b9
000154151 7001_ $$aKemmling, Yvonne$$b10
000154151 7001_ $$aKerrinnes, Tobias$$b11
000154151 7001_ $$aLange, Berit$$b12
000154151 7001_ $$aMikolajczyk, Rafael$$b13
000154151 7001_ $$aNieters, Alexandra$$b14
000154151 7001_ $$aOtt, Jördis J$$b15
000154151 7001_ $$aAhrens, Wolfgang$$b16
000154151 7001_ $$aBerger, Klaus$$b17
000154151 7001_ $$aMeinke-Franze, Claudia$$b18
000154151 7001_ $$aGastell, Sylvia$$b19
000154151 7001_ $$aGünther, Kathrin$$b20
000154151 7001_ $$0P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aGreiser, Karin Halina$$b21$$udkfz
000154151 7001_ $$aHolleczek, Bernd$$b22
000154151 7001_ $$aHorn, Johannes$$b23
000154151 7001_ $$aJaeschke, Lina$$b24
000154151 7001_ $$aJagodzinski, Annika$$b25
000154151 7001_ $$0P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aJansen, Lina$$b26$$udkfz
000154151 7001_ $$aJochem, Carmen$$b27
000154151 7001_ $$aJöckel, Karl-Heinz$$b28
000154151 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, Rudolf$$b29$$udkfz
000154151 7001_ $$aKrist, Lilian$$b30
000154151 7001_ $$aKuß, Oliver$$b31
000154151 7001_ $$aLanger, Susan$$b32
000154151 7001_ $$aLegath, Nicole$$b33
000154151 7001_ $$aLeitzmann, Michael$$b34
000154151 7001_ $$aLieb, Wolfgang$$b35
000154151 7001_ $$aLoeffler, Markus$$b36
000154151 7001_ $$aMangold, Nina$$b37
000154151 7001_ $$aMichels, Karin B$$b38
000154151 7001_ $$aMeisinger, Christa$$b39
000154151 7001_ $$aObi, Nadia$$b40
000154151 7001_ $$aPischon, Tobias$$b41
000154151 7001_ $$aSchikowski, Tamara$$b42
000154151 7001_ $$aSchipf, Sabine$$b43
000154151 7001_ $$aSchulze, Matthias B$$b44
000154151 7001_ $$aStang, Andreas$$b45
000154151 7001_ $$aWaniek, Sabina$$b46
000154151 7001_ $$aWirkner, Kerstin$$b47
000154151 7001_ $$aWillich, Stefan N$$b48
000154151 7001_ $$aCastell, Stefanie$$b49
000154151 773__ $$0PERI:(DE-600)1470303-8$$a10.1007/s00103-020-03114-x$$n4$$p404-414$$tBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz$$v63$$x1437-1588$$y2020
000154151 909CO $$ooai:inrepo02.dkfz.de:154151$$pVDB
000154151 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aDeutsches Krebsforschungszentrum$$b21$$kDKFZ
000154151 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09$$aDeutsches Krebsforschungszentrum$$b26$$kDKFZ
000154151 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b29$$kDKFZ
000154151 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000154151 9141_ $$y2020
000154151 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000154151 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000154151 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000154151 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBUNDESGESUNDHEITSBLA : 2017
000154151 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000154151 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000154151 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000154151 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000154151 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000154151 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x1
000154151 980__ $$ajournal
000154151 980__ $$aVDB
000154151 980__ $$aI:(DE-He78)C020-20160331
000154151 980__ $$aI:(DE-He78)C070-20160331
000154151 980__ $$aUNRESTRICTED